Thomas Duell
Impact in
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer survivorship and care
- Cancer Immunotherapy and Biomarkers
Papers in
- Hematology 12
- Hematopoietic Stem Cell Transplantation 6
- Acute Myeloid Leukemia Research 5
-
- Lung Cancer Diagnosis and Treatment 11
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Gèrard Socié (5 shared papers)André Tichelli (3 shared papers)Per T Ljungman (3 shared papers)Jane F. Apperley (2 shared papers)Elke Anna Nekolla (2 shared papers)Vera Zietemann (4 shared papers)J. Mittermüller (7 shared papers)HJ Kolb (3 shared papers)
- Journals
- Lung Cancer (3 papers)Strahlentherapie und Onkologie (2 papers)Investigational New Drugs (2 papers)Clinical Cancer Research (2 papers)Genomics (2 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Thomas Duell
48 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 76
- Hematology 438
- Oncology 274
- Pulmonary and Respiratory Medicine 266
- Immunology 80
- Otorhinolaryngology 21
Countries citing papers authored by Thomas Duell
This map shows the geographic impact of Thomas Duell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Duell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Duell more than expected).
Fields of papers citing papers by Thomas Duell
This network shows the impact of papers produced by Thomas Duell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Duell. The network helps show where Thomas Duell may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Duell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 211 | |
| 2 | 1997 | 198 | |
| 3 | 1995 | 170 | |
| 4 | 2008 | 94 | |
| 5 | 2015 | 88 | |
| 6 | 2008 | 63 | |
| 7 | 2020 | 56 | |
| 8 | 1998 | 34 | |
| 9 | 2021 | 34 | |
| 10 | 1995 | 29 | |
| 11 | 2010 | 25 | |
| 12 | 2017 | 25 | |
| 13 | 1999 | 24 | |
| 14 | 2021 | 24 | |
| 15 | 2019 | 23 | |
| 16 | Elevated plasma endothelin concentrations in cyclosporine-treated patients after bone marrow transplantation. | 1995 | 22 |
| 17 | 2019 | 21 | |
| 18 | 2009 | 18 | |
| 19 | 1996 | 17 | |
| 20 | Clinical relevance of thymidine kinase for the diagnosis, therapy monitoring and prognosis of non-operable lung cancer. | 2010 | 17 |
About Thomas Duell
Thomas Duell is a scholar working on Hematology, Pulmonary and Respiratory Medicine, Oncology, Genetics and Epidemiology, having authored 50 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (11 papers), Hematopoietic Stem Cell Transplantation (6 papers), Genomic variations and chromosomal abnormalities (6 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Acute Myeloid Leukemia Research (5 papers), Multiple and Secondary Primary Cancers (3 papers) and Genome Rearrangement Algorithms (3 papers). The work is most often cited by research in Hematology (438 citations), Oncology (274 citations), Pulmonary and Respiratory Medicine (266 citations), Immunology (80 citations) and Otorhinolaryngology (21 citations). Thomas Duell has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Gèrard Socié, André Tichelli, Per T Ljungman, Jane F. Apperley, Elke Anna Nekolla, Vera Zietemann, J. Mittermüller, HJ Kolb, H. J. Kolb and Maria Teresa Van Lint. Their work appears in journals such as Lung Cancer, Strahlentherapie und Onkologie, Investigational New Drugs, Clinical Cancer Research and Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.